English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52843263    Online Users :  661
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"shih j y"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 201-250 of 1137  (23 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-11-03T05:24:52Z Tyrosine kinase inhibitors improved survival of critically ill egfr-mutant lung cancer patients undergoing mechanical ventilation Lee I.-H.; Yang C.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2021-10-08T08:16:35Z The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction Chang Y.-L.; MONG-WEI LIN; Shih J.-Y.; Wu C.-T.; Lee Y.-C.
臺大學術典藏 2021-10-08T08:16:33Z Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimension MONG-WEI LIN; Wu C.-T.; Shih J.-Y.; Chang Y.-L.; Yang P.-C.
臺大學術典藏 2021-10-08T08:16:13Z Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; MONG-WEI LIN; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.
臺大學術典藏 2021-10-04T07:15:44Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-10-04T07:15:41Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-10-04T07:15:39Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-10-04T07:15:37Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-10-04T07:15:37Z Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-10-04T07:15:36Z Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions Yu K.-L.; Yang S.-M.; Ko H.-J.; Tsai H.-Y.; JEN-CHANG KO; Lin C.-K.; Ho C.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T05:56:07Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T05:56:06Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation LI-TA KENG; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T05:56:03Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; LI-TA KENG; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T05:56:02Z Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study Lee M.-R.; Huang H.-L.; LI-TA KENG; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T05:41:27Z Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; KAI-LUN YU; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏 2021-09-17T05:41:26Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer KAI-LUN YU; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y.
臺大學術典藏 2021-09-17T05:41:23Z Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions KAI-LUN YU; Yang S.-M.; Ko H.-J.; Tsai H.-Y.; Ko J.-C.; Lin C.-K.; Ho C.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T03:21:19Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma SHENG-KAI LIANG; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T03:21:18Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study SHENG-KAI LIANG; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T03:21:18Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Keng L.-T.; Chung K.-P.; Lin S.-Y.; SHENG-KAI LIANG; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T03:21:17Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-09-17T03:21:16Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T02:51:01Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T02:50:57Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2021-09-17T02:50:52Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T02:50:51Z Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study MENG-RUI LEE; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-15T01:20:52Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2021-09-15T01:20:50Z MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Wang H.-Y.; Liu Y.-N.; Wu S.-G.; CHIA-LANG HSU; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.
臺大學術典藏 2021-09-15T01:20:46Z Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; CHIA-LANG HSU; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.
臺大學術典藏 2021-09-09T05:25:29Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2021-09-09T05:25:27Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-09-02T00:08:47Z Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning Wang Y.-W;Chen C.-J;Huang H.-C;Wang T.-C;Chen H.-M;Shih J.-Y;Chen J.-S;Huang Y.-S;Chang Y.-C;Chang R.-F.; Wang Y.-W; Chen C.-J; Huang H.-C; Wang T.-C; Chen H.-M; Shih J.-Y; Chen J.-S; Huang Y.-S; Chang Y.-C; Chang R.-F.; RUEY-FENG CHANG
臺大學術典藏 2021-09-01T01:54:28Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏 2021-09-01T01:54:26Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:21Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏 2021-09-01T01:53:45Z Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:47Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; Lan K.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏 2021-08-31T06:29:18Z Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏 2021-08-31T05:44:41Z A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor LUN-CHE CHEN; Shih J.-Y.; Yu C.-J.; Yang C.-Y.
臺大學術典藏 2021-08-31T05:27:02Z Effects of left atrial strain on functional capacity in chronic severe mitral regurgitation LI-TAN YANG; Shih J.-Y.; Liu Y.-W.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏 2021-08-31T05:27:00Z Predictive value of left atrial deformation on prognosis in severe primary mitral regurgitation LI-TAN YANG; Liu Y.-W.; Shih J.-Y.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏 2021-08-31T03:33:46Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Keng L.-T.; Chung K.-P.; SHU-YUNG LIN; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-08-31T03:33:46Z 151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs Liao B.-C.; Bai Y.-Y.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J.
臺大學術典藏 2021-08-31T03:33:45Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2021-08-31T03:33:45Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2021-08-31T03:33:44Z Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma Lu H.-H.; SHU-YUNG LIN; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; Yu C.-J.; Tsai H.-C.
臺大學術典藏 2021-08-24T02:10:12Z Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; TAO-MIN HUANG; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-08-24T00:33:36Z The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma YAO-WEN KUO; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-24T00:33:36Z Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation YAO-WEN KUO; Wu S.-G.; Ho C.-C.; Shih J.-Y.
臺大學術典藏 2021-08-24T00:33:35Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; YAO-WEN KUO; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.

Showing items 201-250 of 1137  (23 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page